This inventor holds 1 USPTO granted patent. Top assignee: Mereo Biopharma 1 Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Alastair McKinnon: Innovator in Chronic Obstructive Pulmonary Disease Treatment
Introduction
Alastair McKinnon is a notable inventor based in London, GB, recognized for his significant contributions to the field of pharmaceuticals. With a strong background in research and development, he has made strides in finding effective treatments for chronic conditions. His commitment to innovation is exemplified by his patented work focused on Chronic Obstructive Pulmonary Disease (COPD).
Latest Patents
Alastair holds one patent titled "Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease." This innovative invention addresses the administration of pharmaceutical compositions designed to treat patients suffering from COPD, aiming to prevent and manage acute exacerbations effectively. The patent outlines dosage regimens that could improve patient outcomes and reduce treatment failures associated with this debilitating condition.
Career Highlights
McKinnon is currently affiliated with Mereo Biopharma 1 Limited, a company that is pushing the boundaries of biopharmaceutical innovation. His work at Mereo reflects a dedication to developing therapies that respond to unmet medical needs, especially within the realm of respiratory diseases. His research endeavors are marked by a drive to enhance the quality of life for patients affected by chronic illnesses.
Collaborations
During his career, Alastair has collaborated with key professionals, including Jacqueline Parkin, enhancing the research and development processes of their projects. These collaborations have been instrumental in expanding the scope and impact of their innovative therapies, particularly in the management of COPD.
Conclusion
Alastair McKinnon's contributions to the field of medicine through his invention and ongoing work at Mereo Biopharma highlight the importance of innovation in improving healthcare. His focus on tackling the challenges presented by COPD aims to bring new hope to patients worldwide. As the medical landscape evolves, inventors like McKinnon play a crucial role in shaping effective solutions for chronic health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile